221 related articles for article (PubMed ID: 18035147)
1. Glucose tolerance, insulin secretion, and insulin sensitivity in children and adolescents with cystic fibrosis and no prior history of diabetes.
Elder DA; Wooldridge JL; Dolan LM; D'Alessio DA
J Pediatr; 2007 Dec; 151(6):653-8. PubMed ID: 18035147
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities in glucose tolerance are common in children with fanconi anemia and associated with impaired insulin secretion.
Elder DA; D'Alessio DA; Eyal O; Mueller R; Smith FO; Kansra AR; Rose SR
Pediatr Blood Cancer; 2008 Aug; 51(2):256-60. PubMed ID: 18454466
[TBL] [Abstract][Full Text] [Related]
3. Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis.
Tofé S; Moreno JC; Máiz L; Alonso M; Escobar H; Barrio R
Eur J Endocrinol; 2005 Feb; 152(2):241-7. PubMed ID: 15745932
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of glucose intolerance in cystic fibrosis.
Mohan K; Miller H; Dyce P; Grainger R; Hughes R; Vora J; Ledson M; Walshaw M
Diabet Med; 2009 Jun; 26(6):582-8. PubMed ID: 19538232
[TBL] [Abstract][Full Text] [Related]
5. Glucose intolerance in cystic fibrosis as a determinant of pulmonary function and clinical status.
Lavie M; Fisher D; Vilozni D; Forschmidt R; Sarouk I; Kanety H; Hemi R; Efrati O; Modan-Moses D
Diabetes Res Clin Pract; 2015 Dec; 110(3):276-84. PubMed ID: 26508676
[TBL] [Abstract][Full Text] [Related]
6. β-Cell secretory defects are present in pancreatic insufficient cystic fibrosis with 1-hour oral glucose tolerance test glucose ≥155 mg/dL.
Nyirjesy SC; Sheikh S; Hadjiliadis D; De Leon DD; Peleckis AJ; Eiel JN; Kubrak C; Stefanovski D; Rubenstein RC; Rickels MR; Kelly A
Pediatr Diabetes; 2018 Nov; 19(7):1173-1182. PubMed ID: 29885044
[TBL] [Abstract][Full Text] [Related]
7. Reduced pancreatic insulin release and reduced peripheral insulin sensitivity contribute to hyperglycaemia in cystic fibrosis.
Holl RW; Heinze E; Wolf A; Rank M; Teller WM
Eur J Pediatr; 1995 May; 154(5):356-61. PubMed ID: 7641765
[TBL] [Abstract][Full Text] [Related]
8. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
[TBL] [Abstract][Full Text] [Related]
9. Glucose Tolerance Stages in Cystic Fibrosis Are Identified by a Unique Pattern of Defects of Beta-Cell Function.
Piona C; Volpi S; Zusi C; Mozzillo E; Tosco A; Franzese A; Raia V; Boselli ML; Trombetta M; Cipolli M; Bonadonna RC; Maffeis C
J Clin Endocrinol Metab; 2021 Mar; 106(4):e1793-e1802. PubMed ID: 33331877
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance with altered secretory kinetics and reduced proinsulin in cystic fibrosis patients.
Holl RW; Wolf A; Thon A; Bernhard M; Buck C; Missel M; Heinze E; von der Hardt H; Teller WM
J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):188-93. PubMed ID: 9252906
[TBL] [Abstract][Full Text] [Related]
11. [Insulin secretion and insulin sensitivity in 1193 inpatients with essential hypertension].
Tang XF; Li H; Wang JG; Chu SL; Guo JZ; Zhu DL
Zhonghua Nei Ke Za Zhi; 2004 Oct; 43(10):735-9. PubMed ID: 15631823
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.
Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L
Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance, β-cell dysfunction and differences in curves of plasma glucose and insulin in the intermediate points of the standard glucose tolerance test in adults with cystic fibrosis.
Cano Megías M; González Albarrán O; Guisado Vasco P; Lamas Ferreiro A; Máiz Carro L
Endocrinol Nutr; 2015 Feb; 62(2):91-9. PubMed ID: 25444978
[TBL] [Abstract][Full Text] [Related]
14. Insulin sensitivity and secretion in Arab Americans with glucose intolerance.
Salinitri FD; Pinelli NR; Martin ET; Jaber LA
Diabetes Technol Ther; 2013 Dec; 15(12):1019-24. PubMed ID: 23919587
[TBL] [Abstract][Full Text] [Related]
15. Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects.
Miyazaki Y; Akasaka H; Ohnishi H; Saitoh S; DeFronzo RA; Shimamoto K
Hypertens Res; 2008 Jul; 31(7):1357-63. PubMed ID: 18957806
[TBL] [Abstract][Full Text] [Related]
16. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
Viswanathan V; Clementina M; Nair BM; Satyavani K
J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
[TBL] [Abstract][Full Text] [Related]
17. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction.
Yung B; Noormohamed FH; Kemp M; Hooper J; Lant AF; Hodson ME
Diabet Med; 2002 Mar; 19(3):221-6. PubMed ID: 11963922
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel.
Shalitin S; Abrahami M; Lilos P; Phillip M
Int J Obes (Lond); 2005 Jun; 29(6):571-8. PubMed ID: 15889115
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance.
Bock G; Dalla Man C; Campioni M; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Rizza R
Diabetes; 2006 Dec; 55(12):3536-49. PubMed ID: 17130502
[TBL] [Abstract][Full Text] [Related]
20. The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis.
Ripa P; Robertson I; Cowley D; Harris M; Masters IB; Cotterill AM
Clin Endocrinol (Oxf); 2002 Mar; 56(3):383-9. PubMed ID: 11940051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
